354 related articles for article (PubMed ID: 13489165)
41. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon.
Costa M; Furness JB
Br J Pharmacol; 1979 Feb; 65(2):237-48. PubMed ID: 32947
[TBL] [Abstract][Full Text] [Related]
42. Effect of epinephrine on adrenal ascorbic acid following premedication with lysergic acid diethylamides or 5-hydroxyindolalkylamines.
COSTA E; ZETLER G
Proc Soc Exp Biol Med; 1958 Jun; 98(2):249-52. PubMed ID: 13554608
[No Abstract] [Full Text] [Related]
43. A study of LSD-serotonin central interaction.
ZANOWIAK P; RODMAN MJ
J Am Pharm Assoc Am Pharm Assoc; 1959 Mar; 48(3):165-8. PubMed ID: 13641044
[No Abstract] [Full Text] [Related]
44. On the nature of the chemical mediators involved in anaphylactic reactions in mice.
HALPERN BN; NEVEU T; SPECTOR S
Br J Pharmacol Chemother; 1963 Jun; 20(3):389-98. PubMed ID: 13952224
[TBL] [Abstract][Full Text] [Related]
45. A study of antagonists of 5-hydroxytryptamine and catechol amines on the rat's blood pressure.
OUTSCHOORN AS; JACOB J
Br J Pharmacol Chemother; 1960 Mar; 15(1):131-9. PubMed ID: 14429484
[TBL] [Abstract][Full Text] [Related]
46. Photoreactivity of lysergic acid diethylamide and its possible utility as a photoaffinity labeling reagent.
Walker EB; McNall SJ; Mansour TE
Biochem Pharmacol; 1983 Apr; 32(7):1251-7. PubMed ID: 6847715
[TBL] [Abstract][Full Text] [Related]
47. Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut.
Innes IR; Kohli JD
Br J Pharmacol; 1969 Mar; 35(3):383-93. PubMed ID: 5809731
[TBL] [Abstract][Full Text] [Related]
48. Immunocytochemical demonstration of 5-hydroxytryptamine (serotonin) in the nervous system of the liver fluke, Fasciola hepatica (Trematoda, Digenea).
Fairweather I; Maule AG; Mitchell SH; Johnston CF; Halton DW
Parasitol Res; 1987; 73(3):255-8. PubMed ID: 3295862
[TBL] [Abstract][Full Text] [Related]
49. THE SITE OF THE 5-HYDROXYTRYPTAMINE RECEPTOR ON THE INTRAMURAL NERVOUS PLEXUS OF THE GUINEA-PIG ISOLATED ILEUM.
BROWNLEE G; JOHNSON ES
Br J Pharmacol Chemother; 1963 Oct; 21(2):306-22. PubMed ID: 14081661
[TBL] [Abstract][Full Text] [Related]
50. Effects of psychotomimetic compounds on human pseudocholinesterase.
FRIED GH; ANTOPOL W
J Appl Physiol; 1957 Jul; 11(1):25-8. PubMed ID: 13462913
[No Abstract] [Full Text] [Related]
51. Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.
GUNN CG
Psychiatr Res Rep Am Psychiatr Assoc; 1960 Jan; 12():194-203. PubMed ID: 13851827
[No Abstract] [Full Text] [Related]
52. A study of the action of antimonial compounds on the liver fluke (Fasciola hepatica) in vitro.
MANSOUR TE
Br J Pharmacol Chemother; 1951 Dec; 6(4):588-92. PubMed ID: 14904883
[No Abstract] [Full Text] [Related]
53. Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.
Pierce PA; Peroutka SJ
Neuropsychopharmacology; 1990; 3(5-6):503-8. PubMed ID: 2078283
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy of parasitic worms: new biochemical strategies.
Mansour TE
Science; 1979 Aug; 205(4405):462-9. PubMed ID: 156397
[TBL] [Abstract][Full Text] [Related]
55. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
56. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.
SALMOIRAGHI GC; SOLLERO L; PAGE IH
J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558
[No Abstract] [Full Text] [Related]
57. Actions of certain amines on cerebral cortical neurones.
KRNJEVIC K; PHILLIS JW
Br J Pharmacol Chemother; 1963 Jun; 20(3):471-90. PubMed ID: 14035890
[TBL] [Abstract][Full Text] [Related]
58. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
Winter JC
J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
[No Abstract] [Full Text] [Related]
59. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
[TBL] [Abstract][Full Text] [Related]
60. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
Burris KD; Breeding M; Sanders-Bush E
J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
